Anthem Bioscienc

{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "784.20",
    "chg": -0.45,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "784.65",
    "mcapval": "43,260.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0CZ201020",
    "curr_date": "May 11",
    "curr_time": "",
    "bse_nse_vol": "7.61 lacs",
    "exc_status": "Active",
    "traded_date": "May 11, 2026",
    "traded_date_str": "2026 05 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anthem-bioscienc-10039665-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Market Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-to-mildly-bullish-amid-market-outperformance-3984849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_technicaldot_3984849.png",
        "date": "2026-05-11 08:03:44",
        "description": "Anthem Biosciences Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by a combination of bullish weekly MACD and Bollinger Bands signals, alongside mixed monthly indicators and a recent downgrade in its Mojo Grade from Hold to Sell, reflecting a complex market outlook for this mid-cap pharmaceutical player."
      },
      {
        "title": "Anthem Biosciences Gains 2.68%: Mixed Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-gains-268-mixed-signals-shape-weekly-momentum-3982596",
        "imagepath": "",
        "date": "2026-05-09 09:02:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.764.10</p>\n                    <p><strong>5 May:</strong> Stock dips 0.42% amid broader market weakness</p>\n                    <p><strong>6 May:</strong> Sharp rebound with 0.99% gain as Sensex rallies</p>\n                    <p><strong>7 May:</strong> Strong 1.37% rise following technical momentum shift</p>\n                    <p><strong>8 May:</strong> MarketsMOJO downgrades stock to Sell; closes at Rs.784.55 (+0.73%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.764.10</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "Anthem Biosciences Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3980978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_mojoScore_3980978.png",
        "date": "2026-05-08 08:24:43",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 May 2026. This decision follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some long-term growth indicators, recent quarterly results and shifting technical trends have raised concerns among analysts, prompting a more cautious stance on the stock."
      },
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3980892",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_technicaldot_3980892.png",
        "date": "2026-05-08 08:06:02",
        "description": "Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a 1.37% gain on 8 May 2026, the stock’s technical signals present a mixed picture, prompting a downgrade in its Mojo Grade from Hold to Sell on 7 May 2026."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-by-marketsmojo-3975778",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_mojoScore_3975778.png",
        "date": "2026-05-05 10:10:17",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-3960639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_mojoScore_3960639.png",
        "date": "2026-04-24 10:10:16",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 April 2026."
      },
      {
        "title": "Anthem Biosciences Ltd Upgraded to Hold on Technical and Financial Reassessment",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-upgraded-to-hold-on-technical-and-financial-reassessment-3944217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_mojoScore_3944217.png",
        "date": "2026-04-13 08:26:55",
        "description": "Anthem Biosciences Ltd has seen its investment rating upgraded from Sell to Hold as of 10 April 2026, reflecting a notable improvement in technical indicators alongside steady fundamental performance despite recent quarterly setbacks. The mid-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 50.0, signalling a more balanced outlook for investors amid mixed financial trends and valuation concerns."
      },
      {
        "title": "Anthem Biosciences Gains 12.28%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-gains-1228-6-key-factors-driving-the-weeks-momentum-3942185",
        "imagepath": "",
        "date": "2026-04-11 09:02:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Mojo Grade downgraded to Sell amid technical and financial weakness</p>\n                    <p><strong>7 Apr:</strong> Technical momentum shifts to sideways trend with mixed signals</p>\n                    <p><strong>8 Apr:</strong> Mildly bullish momentum emerges with technical upgrades</p>\n                    <p><strong>9 Apr:</strong> Intraday high of ₹728.5 with a 5.83% surge</p>\n                    <p><strong>9 Apr:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>10 Apr:</strong> Technical momentum shifts to mildly bullish with strong price gains</p>\n                </div>\n\n                <div class=\"stats-row\">..."
      },
      {
        "title": "Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-sees-technical-momentum-shift-amid-strong-price-gains-3941032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_technicaldot_3941032.png",
        "date": "2026-04-10 08:04:36",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, signalling a cautiously optimistic outlook after a period of subdued performance. The stock’s recent 4.76% intraday gain to ₹722.70, coupled with upgrades in key technical parameters, suggests a mild bullish trend emerging in the near term."
      }
    ],
    "total": 33,
    "sid": "10039665",
    "stock_news_url": "https://www.marketsmojo.com/news/anthem-biosciences-10039665"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Market Outperformance

2026-05-11 08:03:44

Anthem Biosciences Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by a combination of bullish weekly MACD and Bollinger Bands signals, alongside mixed monthly indicators and a recent downgrade in its Mojo Grade from Hold to Sell, reflecting a complex market outlook for this mid-cap pharmaceutical player.

Read full news article

Anthem Biosciences Gains 2.68%: Mixed Signals Shape Weekly Momentum

2026-05-09 09:02:46

Key Events This Week

4 May: Week opens at Rs.764.10

5 May: Stock dips 0.42% amid broader market weakness

6 May: Sharp rebound with 0.99% gain as Sensex rallies

7 May: Strong 1.37% rise following technical momentum shift

8 May: MarketsMOJO downgrades stock to Sell; closes at Rs.784.55 (+0.73%)

Week Open

Rs.764.10

Read full news article

Anthem Biosciences Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-05-08 08:24:43

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 May 2026. This decision follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some long-term growth indicators, recent quarterly results and shifting technical trends have raised concerns among analysts, prompting a more cautious stance on the stock.

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-08 08:06:02

Anthem Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a 1.37% gain on 8 May 2026, the stock’s technical signals present a mixed picture, prompting a downgrade in its Mojo Grade from Hold to Sell on 7 May 2026.

Read full news article

Anthem Biosciences Ltd is Rated Hold by MarketsMOJO

2026-05-05 10:10:17

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Anthem Biosciences Ltd is Rated Hold

2026-04-24 10:10:16

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 April 2026.

Read full news article

Anthem Biosciences Ltd Upgraded to Hold on Technical and Financial Reassessment

2026-04-13 08:26:55

Anthem Biosciences Ltd has seen its investment rating upgraded from Sell to Hold as of 10 April 2026, reflecting a notable improvement in technical indicators alongside steady fundamental performance despite recent quarterly setbacks. The mid-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 50.0, signalling a more balanced outlook for investors amid mixed financial trends and valuation concerns.

Read full news article

Anthem Biosciences Gains 12.28%: 6 Key Factors Driving the Week’s Momentum

2026-04-11 09:02:37

Key Events This Week

6 Apr: Mojo Grade downgraded to Sell amid technical and financial weakness

7 Apr: Technical momentum shifts to sideways trend with mixed signals

8 Apr: Mildly bullish momentum emerges with technical upgrades

9 Apr: Intraday high of ₹728.5 with a 5.83% surge

9 Apr: Technical momentum shifts amid mixed market signals

10 Apr: Technical momentum shifts to mildly bullish with strong price gains

...

Read full news article

Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains

2026-04-10 08:04:36

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, signalling a cautiously optimistic outlook after a period of subdued performance. The stock’s recent 4.76% intraday gain to ₹722.70, coupled with upgrades in key technical parameters, suggests a mild bullish trend emerging in the near term.

Read full news article

View All News